What is VANI's dilution risk score?

VANI has a latest available DilutionScore record of 48/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for VANI, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for VANI?

DilutionWatch tracks 25 SEC filing types for VANI including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect VANI shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For VANI, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for VANI tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for VANI. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

VANI Dilution Risk Score: 48/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

46

💰 Cash Runway

65

📊 Float Risk

37

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 24%

🔄 Reverse Split model est. 40%

• 50-day avg $1.20 approaching $1 threshold

• 10 months cash with weak price

💰 Capital Raise model 15%

• Under 12 months cash (10mo)

🔔 Track VANI — Get forecast alerts →

Market Data

Market Cap$113.83M

Shares Outstanding90.20M

Float38.86M

Cash$19.89M

Debt$2.20M

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	48/100	DilutionWatch score record
Shares Outstanding	90.20M	Verified float table or market cache
Public Float	38.86M	Verified float table or market cache
Market Cap	$113.83M	Market data cache
Cash Runway	10.5 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	927.2K	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: FORM 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 31.3% shares (2026Q1 vs prior)

45 institutional holders · 7.25M shares

#1 VANGUARD CAPITAL MANAGEMENT LLC 3.06M shares

#2 Tanager Wealth Management LLP 641.1K shares

#3 GEODE CAPITAL MANAGEMENT, LLC 600.6K shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest495.2K

Days to Cover2.2

% of Float1.3%

FINRA data as of Aug 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2024-12-31

xbrl XBRL CONVERTIBLE 2016-12-31

Form 4 INSIDER TRANSACTION 2026-07-28

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual VANI Dilution Snapshot

Vivani Medical, Inc. (VANI) has a DilutionScore of 48/100, rated Medium dilution risk. Score date: September 12, 2026.

Stored outstanding warrants: 927,152.
Recent SEC activity tracked for VANI: Form 4 on 2026-07-28; Form 4 on 2026-07-28; Form 4 on 2026-07-28.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,348+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

More Research for VANI

VANI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

VANI — Vivani Medical, Inc. Dilution Risk Tracker